What the market wants from AMBS is LymPro revenue,
Post# of 30028
Posted On: 09/17/2014 2:36:42 PM
What the market wants from AMBS is LymPro revenue, which is still a few months away..... or a LymPro JV Partnership! That has always been what gives AMBS it's value. When the market thinks a LymPro JV Partner is near, the pps creeps up. When those hopes are dashed, the pps falls. It's that simple.
MANF & Elto data announcements don't really pop us up.
I don't think management is very in tune with the market, they never have been. If they have a surprise announcement that pops our pps up, then great, the billion share vote won't hurt us much. If they don't have a big surprise, we will struggle till December when we get LymPro commercialization, the media blitz, and MANF orphans.
MANF & Elto data announcements don't really pop us up.
I don't think management is very in tune with the market, they never have been. If they have a surprise announcement that pops our pps up, then great, the billion share vote won't hurt us much. If they don't have a big surprise, we will struggle till December when we get LymPro commercialization, the media blitz, and MANF orphans.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼